SUBSCRIBE
SUBSCRIBE
News   FDA

Russia First To Approve Merck KGaA Multiple Sclerosis Pill Cladribine

July 12, 2010 | 
1 min read

FRANKFURT, July 12 (Reuters) - Russia is the first country to approve Merck KGaA’s (MRCG.DE) new multiple sclerosis pill cladribine, giving the German drugmaker an edge in the emerging market against larger rival Novartis AG (NOVN.VX).

FDA Approvals Asia Europe
MORE ON THIS TOPIC
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
The court's decision cancels all agreements. Agreement between the parties to the dispute. Conflict resolution in court.
COVID-19
FDA Shoots Down Invivyd’s Bid to Expand EUA for COVID-19 Antibody
February 24, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA signage at its headquarters in Maryland
Government
FDA to Rehire Scientists After Trump’s Firing Spree: Reuters
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac